NVAX

Novavax Inc

7.34

USD

NVAX Earnings Reports

Positive Surprise Ratio

NVAX beat 17 of 40 last estimates.

43%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$80.88M

-$0.49

Implied change from Q3 25 (Revenue/ EPS)

+14.81%

-60.80%

Implied change from Q4 24 (Revenue/ EPS)

-8.41%

-40.96%

Novavax Inc earnings per share and revenue

On Nov 06, 2025, NVAX reported earnings of -1.25 USD per share (EPS) for Q3 25, missing the estimate of -1.21 USD, resulting in a -3.31% surprise. Revenue reached 70.44 million, compared to an expected 42.98 million, with a 63.92% difference. The market reacted with a -1.30% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.49 USD, with revenue projected to reach 80.88 million USD, implying an decrease of -60.80% EPS, and increase of 14.81% in Revenue from the last quarter.

FAQ

What were Novavax Inc's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Novavax Inc reported EPS of -$1.25, missing estimates by -3.31%, and revenue of $70.44M, 63.92% above expectations.

How did the market react to Novavax Inc's Q3 2025 earnings?

The stock price moved down -1.3%, changed from $7.69 before the earnings release to $7.59 the day after.

When is Novavax Inc expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Novavax Inc's next earnings report?

Based on 10 analysts, Novavax Inc is expected to report EPS of -$0.49 and revenue of $80.88M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.